# Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial

> **NCT06949228** · PHASE2,PHASE3 · RECRUITING · sponsor: **ProMedica Health System** · enrollment: 132 (estimated)

## Conditions studied

- Ischemic Stroke
- Acute Disease

## Interventions

- **DRUG:** tenecteplase

## Key facts

- **NCT ID:** NCT06949228
- **Lead sponsor:** ProMedica Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-30
- **Primary completion:** 2028-05-30
- **Final completion:** 2028-05-30
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06949228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06949228, "Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06949228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*